2. Losses widen for DJO Global as it exits the Empi distributorship business
Fourth-quarter and full-year losses widened for DJO Global, as it completed the exit of its Empi orthopedic stimulation business. Read more
More recent news
- GT Medical Technologies brings in $35M for bioresorbable radiation tile
- FDA clears tissue scanner from SamanTree Medical
- GE HealthCare prices upsized offering worth $1.3B
- Boston Scientific expected to close Silk Road Medical acquisition soon after antitrust waiting period expires
- MicroVention rebrands to Terumo Neuro
